title: Screening LRRK2 gene mutations in patients with Parkinson's disease in Ghana.
authors.forename: Roberto
authors.initials: R
authors.lastname: Cilia
authors.forename: Francesca
authors.initials: F
authors.lastname: Sironi
authors.forename: Albert
authors.initials: A
authors.lastname: Akpalu
authors.forename: Momodou
authors.initials: M
authors.lastname: Cham
authors.forename: Fred Stephen
authors.initials: FS
authors.lastname: Sarfo
authors.forename: Tiziana
authors.initials: T
authors.lastname: Brambilla
authors.forename: Alba
authors.initials: A
authors.lastname: Bonetti
authors.forename: Marianna
authors.initials: M
authors.lastname: Amboni
authors.forename: Stefano
authors.initials: S
authors.lastname: Goldwurm
authors.forename: Gianni
authors.initials: G
authors.lastname: Pezzoli
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D020022:Genetic Predisposition to Disease; D005820:Genetic Testing; D005869:Ghana / Q000453:epidemiology; D006801:Humans; D000071158:Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; D008297:Male; D008875:Middle Aged; D009154:Mutation / Q000235:genetics*; D010300:Parkinson Disease / Q000453:epidemiology / Q000235:genetics*; D017346:Protein Serine-Threonine Kinases / Q000235:genetics*; D012189:Retrospective Studies
chemical_list: C495280:LRRK2 protein, human; D000071158:Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; D017346:Protein Serine-Threonine Kinases